Opioid utilization patterns in United States individuals with sickle cell disease

被引:34
作者
Ballas, Samir K. [1 ]
Kanter, Julie [2 ]
Agodoa, Irene [3 ]
Howard, Robin [3 ]
Wade, Sally [4 ]
Noxon, Virginia [5 ]
Dampier, Carlton [6 ]
机构
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Med Univ South Carolina, Charleston, SC 29425 USA
[3] Global Blood Therapeut, San Francisco, CA USA
[4] Wade Outcomes Res & Consulting, Salt Lake City, UT USA
[5] IBM Watson Hlth, Cambridge, MA USA
[6] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
D O I
10.1002/ajh.25233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E345 / E347
页数:3
相关论文
共 7 条
[1]  
Center for Disease Control and Prevention, 2016, SICKL CELL DIS DAT S
[2]  
Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]
[3]   Characterization of opioid use in sickle cell disease [J].
Han, Jin ;
Zhou, Jifang ;
Saraf, Santosh L. ;
Gordeuk, Victor R. ;
Calip, Gregory S. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (05) :479-486
[4]   Management of sickle cell disease from childhood through adulthood [J].
Kanter, Julie ;
Kruse-Jarres, Rebecca .
BLOOD REVIEWS, 2013, 27 (06) :279-287
[5]   Insurance Status as a Sociodemographic Risk Factor for Functional Outcomes and Health-related Quality of Life Among Youth With Sickle Cell Disease [J].
Robinson, M. Renee ;
Daniel, Lauren C. ;
O'Hara, Emily A. ;
Szabo, Margo M. ;
Barakat, Lamia P. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (01) :51-56
[6]   The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association [J].
Ruta, Nadia S. ;
Ballas, Samir K. .
PAIN MEDICINE, 2016, 17 (10) :1793-1798
[7]  
United States Census Bureau, 2018, POP EST STAT POP TOT